nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethinyl Estradiol—ABCB1—peripheral nervous system neoplasm	0.278	1	CbGaD
Ethinyl Estradiol—ABCB11—Vincristine—peripheral nervous system neoplasm	0.0644	0.127	CbGbCtD
Ethinyl Estradiol—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0469	0.0923	CbGbCtD
Ethinyl Estradiol—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.0402	0.0793	CbGbCtD
Ethinyl Estradiol—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0355	0.0699	CbGbCtD
Ethinyl Estradiol—ABCC2—Vincristine—peripheral nervous system neoplasm	0.0338	0.0667	CbGbCtD
Ethinyl Estradiol—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0316	0.0622	CbGbCtD
Ethinyl Estradiol—ABCC2—Etoposide—peripheral nervous system neoplasm	0.031	0.0611	CbGbCtD
Ethinyl Estradiol—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0258	0.0509	CbGbCtD
Ethinyl Estradiol—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0258	0.0509	CbGbCtD
Ethinyl Estradiol—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0211	0.0417	CbGbCtD
Ethinyl Estradiol—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0201	0.0395	CbGbCtD
Ethinyl Estradiol—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0179	0.0353	CbGbCtD
Ethinyl Estradiol—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0155	0.0305	CbGbCtD
Ethinyl Estradiol—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0149	0.0294	CbGbCtD
Ethinyl Estradiol—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0144	0.0284	CbGbCtD
Ethinyl Estradiol—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0134	0.0265	CbGbCtD
Ethinyl Estradiol—ABCB1—Vincristine—peripheral nervous system neoplasm	0.011	0.0217	CbGbCtD
Ethinyl Estradiol—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0103	0.0203	CbGbCtD
Ethinyl Estradiol—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0101	0.0199	CbGbCtD
Ethinyl Estradiol—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00689	0.0136	CbGbCtD
Ethinyl Estradiol—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00661	0.013	CbGbCtD
Ethinyl Estradiol—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00606	0.0119	CbGbCtD
Ethinyl Estradiol—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00413	0.00814	CbGbCtD
Ethinyl Estradiol—ESR2—Validated nuclear estrogen receptor beta network—SMARCB1—peripheral nervous system neoplasm	0.00315	0.073	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.00163	0.0378	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.00145	0.0337	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00119	0.0276	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.00101	0.0234	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000936	0.0217	CbGpPWpGaD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000921	0.0214	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000856	0.0198	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000651	0.0151	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000492	0.0114	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.000491	0.0114	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.000483	0.0112	CbGpPWpGaD
Ethinyl Estradiol—SHBG—Nongenotropic Androgen signaling—HRAS—peripheral nervous system neoplasm	0.000467	0.0108	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Estrogen signaling pathway—GNAS—peripheral nervous system neoplasm	0.000463	0.0107	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	0.000428	0.00993	CbGpPWpGaD
Ethinyl Estradiol—SHBG—Nongenotropic Androgen signaling—AKT1—peripheral nervous system neoplasm	0.000412	0.00956	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000412	0.00954	CbGpPWpGaD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—NF1—peripheral nervous system neoplasm	0.000403	0.00933	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000392	0.00909	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000374	0.00866	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000357	0.00827	CbGpPWpGaD
Ethinyl Estradiol—Estriol—ABCB1—peripheral nervous system neoplasm	0.000346	0.265	CrCbGaD
Ethinyl Estradiol—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000344	0.00798	CbGpPWpGaD
Ethinyl Estradiol—ESR1—FOXM1 transcription factor network—CHEK2—peripheral nervous system neoplasm	0.000342	0.00792	CbGpPWpGaD
Ethinyl Estradiol—Estramustine—ABCB1—peripheral nervous system neoplasm	0.000321	0.247	CrCbGaD
Ethinyl Estradiol—SLC10A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000314	0.00728	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.000307	0.00712	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000292	0.00677	CbGpPWpGaD
Ethinyl Estradiol—ESR1—ATF-2 transcription factor network—TH—peripheral nervous system neoplasm	0.000267	0.00618	CbGpPWpGaD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000265	0.00615	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.00025	0.0058	CbGpPWpGaD
Ethinyl Estradiol—ESR1—FOXM1 transcription factor network—BIRC5—peripheral nervous system neoplasm	0.000248	0.00574	CbGpPWpGaD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000243	0.00563	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	0.000241	0.0056	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000238	0.00552	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	0.000233	0.00539	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Nuclear signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	0.000211	0.00488	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—IFNB1—peripheral nervous system neoplasm	0.000208	0.00483	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.000208	0.00481	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000207	0.0048	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—EED—peripheral nervous system neoplasm	0.000202	0.00468	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000202	0.00468	CbGpPWpGaD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000198	0.00459	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.00019	0.0044	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000188	0.00437	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000185	0.00429	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000184	0.00426	CbGpPWpGaD
Ethinyl Estradiol—Norethindrone—ABCB1—peripheral nervous system neoplasm	0.000182	0.139	CrCbGaD
Ethinyl Estradiol—AOX1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000178	0.00413	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	0.000177	0.00409	CbGpPWpGaD
Ethinyl Estradiol—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000172	0.00101	CcSEcCtD
Ethinyl Estradiol—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000172	0.00101	CcSEcCtD
Ethinyl Estradiol—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000172	0.00101	CcSEcCtD
Ethinyl Estradiol—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000171	0.00101	CcSEcCtD
Ethinyl Estradiol—Back pain—Etoposide—peripheral nervous system neoplasm	0.000171	0.001	CcSEcCtD
Ethinyl Estradiol—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00017	0.000996	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.00017	0.000994	CcSEcCtD
Ethinyl Estradiol—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000991	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000168	0.0039	CbGpPWpGaD
Ethinyl Estradiol—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000168	0.000984	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000982	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000166	0.000976	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000166	0.000976	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000166	0.00384	CbGpPWpGaD
Ethinyl Estradiol—Conjugated Estrogens—ABCB1—peripheral nervous system neoplasm	0.000165	0.127	CrCbGaD
Ethinyl Estradiol—Estrone—ABCB1—peripheral nervous system neoplasm	0.000165	0.126	CrCbGaD
Ethinyl Estradiol—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000164	0.000964	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000963	CcSEcCtD
Ethinyl Estradiol—ESR1—FOXM1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000164	0.0038	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000164	0.000961	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000164	0.000959	CcSEcCtD
Ethinyl Estradiol—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000163	0.000958	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000163	0.000954	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000163	0.000954	CcSEcCtD
Ethinyl Estradiol—Hot flush—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000952	CcSEcCtD
Ethinyl Estradiol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000162	0.000951	CcSEcCtD
Ethinyl Estradiol—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000162	0.000949	CcSEcCtD
Ethinyl Estradiol—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000162	0.000948	CcSEcCtD
Ethinyl Estradiol—Migraine—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000947	CcSEcCtD
Ethinyl Estradiol—Affect lability—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000947	CcSEcCtD
Ethinyl Estradiol—NR1I2—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000161	0.00374	CbGpPWpGaD
Ethinyl Estradiol—Menopausal symptoms—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.000944	CcSEcCtD
Ethinyl Estradiol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000161	0.000943	CcSEcCtD
Ethinyl Estradiol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000161	0.000943	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000159	0.000933	CcSEcCtD
Ethinyl Estradiol—Malaise—Etoposide—peripheral nervous system neoplasm	0.000159	0.000933	CcSEcCtD
Ethinyl Estradiol—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000159	0.000932	CcSEcCtD
Ethinyl Estradiol—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000158	0.000925	CcSEcCtD
Ethinyl Estradiol—ESR2—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	0.000157	0.00365	CbGpPWpGaD
Ethinyl Estradiol—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000157	0.000922	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000157	0.000922	CcSEcCtD
Ethinyl Estradiol—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000157	0.000921	CcSEcCtD
Ethinyl Estradiol—Infection—Cisplatin—peripheral nervous system neoplasm	0.000156	0.000915	CcSEcCtD
Ethinyl Estradiol—ESR2—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	0.000156	0.00361	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000156	0.000914	CcSEcCtD
Ethinyl Estradiol—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000912	CcSEcCtD
Ethinyl Estradiol—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000909	CcSEcCtD
Ethinyl Estradiol—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000155	0.000907	CcSEcCtD
Ethinyl Estradiol—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000155	0.000907	CcSEcCtD
Ethinyl Estradiol—Rash—Topotecan—peripheral nervous system neoplasm	0.000155	0.000907	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000154	0.000906	CcSEcCtD
Ethinyl Estradiol—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000154	0.000903	CcSEcCtD
Ethinyl Estradiol—Cough—Etoposide—peripheral nervous system neoplasm	0.000154	0.000902	CcSEcCtD
Ethinyl Estradiol—Headache—Topotecan—peripheral nervous system neoplasm	0.000154	0.000901	CcSEcCtD
Ethinyl Estradiol—Rash—Tretinoin—peripheral nervous system neoplasm	0.000153	0.0009	CcSEcCtD
Ethinyl Estradiol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000153	0.0009	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000153	0.000899	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000153	0.000899	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000153	0.000899	CcSEcCtD
Ethinyl Estradiol—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000153	0.000898	CcSEcCtD
Ethinyl Estradiol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000153	0.000895	CcSEcCtD
Ethinyl Estradiol—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000153	0.000895	CcSEcCtD
Ethinyl Estradiol—Headache—Tretinoin—peripheral nervous system neoplasm	0.000152	0.000894	CcSEcCtD
Ethinyl Estradiol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000152	0.000894	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.000891	CcSEcCtD
Ethinyl Estradiol—Constipation—Vincristine—peripheral nervous system neoplasm	0.000152	0.000891	CcSEcCtD
Ethinyl Estradiol—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000891	CcSEcCtD
Ethinyl Estradiol—Rash—Melphalan—peripheral nervous system neoplasm	0.000151	0.000888	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000151	0.000887	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.000884	CcSEcCtD
Ethinyl Estradiol—Affect lability—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000877	CcSEcCtD
Ethinyl Estradiol—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000877	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000149	0.000874	CcSEcCtD
Ethinyl Estradiol—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000148	0.00087	CcSEcCtD
Ethinyl Estradiol—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000148	0.00087	CcSEcCtD
Ethinyl Estradiol—ABCC2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000148	0.00342	CbGpPWpGaD
Ethinyl Estradiol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000147	0.000859	CcSEcCtD
Ethinyl Estradiol—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000859	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000855	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000855	CcSEcCtD
Ethinyl Estradiol—Nausea—Topotecan—peripheral nervous system neoplasm	0.000146	0.000854	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000145	0.000852	CcSEcCtD
Ethinyl Estradiol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000145	0.000847	CcSEcCtD
Ethinyl Estradiol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000145	0.000847	CcSEcCtD
Ethinyl Estradiol—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000844	CcSEcCtD
Ethinyl Estradiol—Infection—Etoposide—peripheral nervous system neoplasm	0.000143	0.000838	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000838	CcSEcCtD
Ethinyl Estradiol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000143	0.000837	CcSEcCtD
Ethinyl Estradiol—Nausea—Melphalan—peripheral nervous system neoplasm	0.000143	0.000836	CcSEcCtD
Ethinyl Estradiol—ESR2—Gene Expression—EED—peripheral nervous system neoplasm	0.000142	0.00329	CbGpPWpGaD
Ethinyl Estradiol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00014	0.000824	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00014	0.000824	CcSEcCtD
Ethinyl Estradiol—SLC10A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00014	0.00324	CbGpPWpGaD
Ethinyl Estradiol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00014	0.00082	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.000137	0.00318	CbGpPWpGaD
Ethinyl Estradiol—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000805	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000136	0.0008	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000136	0.000798	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000136	0.000797	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000136	0.000795	CcSEcCtD
Ethinyl Estradiol—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000778	CcSEcCtD
Ethinyl Estradiol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000132	0.000776	CcSEcCtD
Ethinyl Estradiol—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000775	CcSEcCtD
Ethinyl Estradiol—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000773	CcSEcCtD
Ethinyl Estradiol—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000769	CcSEcCtD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000131	0.00303	CbGpPWpGaD
Ethinyl Estradiol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000131	0.000768	CcSEcCtD
Ethinyl Estradiol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00013	0.000765	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000129	0.000759	CcSEcCtD
Ethinyl Estradiol—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000757	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000753	CcSEcCtD
Ethinyl Estradiol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000127	0.000748	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000742	CcSEcCtD
Ethinyl Estradiol—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000742	CcSEcCtD
Ethinyl Estradiol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000126	0.000741	CcSEcCtD
Ethinyl Estradiol—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00074	CcSEcCtD
Ethinyl Estradiol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000126	0.00074	CcSEcCtD
Ethinyl Estradiol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000125	0.000735	CcSEcCtD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000125	0.00289	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Estrogen signaling pathway—AKT1—peripheral nervous system neoplasm	0.000125	0.00289	CbGpPWpGaD
Ethinyl Estradiol—Estradiol—ABCB1—peripheral nervous system neoplasm	0.000125	0.0957	CrCbGaD
Ethinyl Estradiol—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000124	0.000729	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000124	0.000728	CcSEcCtD
Ethinyl Estradiol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000124	0.000728	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000727	CcSEcCtD
Ethinyl Estradiol—Constipation—Etoposide—peripheral nervous system neoplasm	0.000123	0.000722	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000721	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000123	0.00285	CbGpPWpGaD
Ethinyl Estradiol—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00072	CcSEcCtD
Ethinyl Estradiol—ABCB11—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000122	0.00283	CbGpPWpGaD
Ethinyl Estradiol—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000715	CcSEcCtD
Ethinyl Estradiol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000122	0.000715	CcSEcCtD
Ethinyl Estradiol—ESR1—Plasma membrane estrogen receptor signaling—NRAS—peripheral nervous system neoplasm	0.000122	0.00282	CbGpPWpGaD
Ethinyl Estradiol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000122	0.000713	CcSEcCtD
Ethinyl Estradiol—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000711	CcSEcCtD
Ethinyl Estradiol—AOX1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00012	0.00279	CbGpPWpGaD
Ethinyl Estradiol—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000701	CcSEcCtD
Ethinyl Estradiol—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000696	CcSEcCtD
Ethinyl Estradiol—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000696	CcSEcCtD
Ethinyl Estradiol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000119	0.000695	CcSEcCtD
Ethinyl Estradiol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000118	0.000693	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000118	0.00069	CcSEcCtD
Ethinyl Estradiol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000117	0.000689	CcSEcCtD
Ethinyl Estradiol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000117	0.000687	CcSEcCtD
Ethinyl Estradiol—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000686	CcSEcCtD
Ethinyl Estradiol—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000686	CcSEcCtD
Ethinyl Estradiol—SLC10A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	0.000116	0.00269	CbGpPWpGaD
Ethinyl Estradiol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.000682	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.000681	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000679	CcSEcCtD
Ethinyl Estradiol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.000677	CcSEcCtD
Ethinyl Estradiol—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000673	CcSEcCtD
Ethinyl Estradiol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000114	0.00067	CcSEcCtD
Ethinyl Estradiol—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000669	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000668	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000114	0.000667	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000114	0.000667	CcSEcCtD
Ethinyl Estradiol—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000667	CcSEcCtD
Ethinyl Estradiol—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000114	0.00263	CbGpPWpGaD
Ethinyl Estradiol—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000666	CcSEcCtD
Ethinyl Estradiol—ESR2—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.000114	0.00263	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000113	0.00262	CbGpPWpGaD
Ethinyl Estradiol—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000663	CcSEcCtD
Ethinyl Estradiol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000113	0.000662	CcSEcCtD
Ethinyl Estradiol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000113	0.000661	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000661	CcSEcCtD
Ethinyl Estradiol—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000658	CcSEcCtD
Ethinyl Estradiol—Rash—Vincristine—peripheral nervous system neoplasm	0.000112	0.000657	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000112	0.000656	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000654	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000653	CcSEcCtD
Ethinyl Estradiol—Headache—Vincristine—peripheral nervous system neoplasm	0.000111	0.000653	CcSEcCtD
Ethinyl Estradiol—ESR1—FOXM1 transcription factor network—MYC—peripheral nervous system neoplasm	0.000111	0.00258	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.000111	0.00257	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00011	0.00255	CbGpPWpGaD
Ethinyl Estradiol—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000644	CcSEcCtD
Ethinyl Estradiol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00011	0.000642	CcSEcCtD
Ethinyl Estradiol—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000642	CcSEcCtD
Ethinyl Estradiol—ESR1—LKB1 signaling events—MYC—peripheral nervous system neoplasm	0.000109	0.00253	CbGpPWpGaD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000109	0.00253	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000108	0.00251	CbGpPWpGaD
Ethinyl Estradiol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000107	0.00063	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00063	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000622	CcSEcCtD
Ethinyl Estradiol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000106	0.000622	CcSEcCtD
Ethinyl Estradiol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.000106	0.00245	CbGpPWpGaD
Ethinyl Estradiol—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000619	CcSEcCtD
Ethinyl Estradiol—Nausea—Vincristine—peripheral nervous system neoplasm	0.000106	0.000619	CcSEcCtD
Ethinyl Estradiol—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000618	CcSEcCtD
Ethinyl Estradiol—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000616	CcSEcCtD
Ethinyl Estradiol—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000613	CcSEcCtD
Ethinyl Estradiol—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000612	CcSEcCtD
Ethinyl Estradiol—AOX1—Disease—GNS—peripheral nervous system neoplasm	0.000104	0.00241	CbGpPWpGaD
Ethinyl Estradiol—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000608	CcSEcCtD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.000103	0.0024	CbGpPWpGaD
Ethinyl Estradiol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000103	0.000606	CcSEcCtD
Ethinyl Estradiol—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000605	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000604	CcSEcCtD
Ethinyl Estradiol—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000604	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000601	CcSEcCtD
Ethinyl Estradiol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000102	0.000597	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000102	0.00236	CbGpPWpGaD
Ethinyl Estradiol—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000594	CcSEcCtD
Ethinyl Estradiol—SLC10A1—Metabolism—GNS—peripheral nervous system neoplasm	0.000101	0.00234	CbGpPWpGaD
Ethinyl Estradiol—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000588	CcSEcCtD
Ethinyl Estradiol—Vomiting—Cisplatin—peripheral nervous system neoplasm	9.99e-05	0.000586	CcSEcCtD
Ethinyl Estradiol—Mental disorder—Epirubicin—peripheral nervous system neoplasm	9.95e-05	0.000583	CcSEcCtD
Ethinyl Estradiol—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.000583	CcSEcCtD
Ethinyl Estradiol—Rash—Cisplatin—peripheral nervous system neoplasm	9.91e-05	0.000581	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	9.9e-05	0.00058	CcSEcCtD
Ethinyl Estradiol—ESR2—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	9.89e-05	0.00229	CbGpPWpGaD
Ethinyl Estradiol—Malnutrition—Epirubicin—peripheral nervous system neoplasm	9.89e-05	0.00058	CcSEcCtD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—ERBB2—peripheral nervous system neoplasm	9.87e-05	0.00229	CbGpPWpGaD
Ethinyl Estradiol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	9.85e-05	0.000577	CcSEcCtD
Ethinyl Estradiol—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	9.82e-05	0.000576	CcSEcCtD
Ethinyl Estradiol—SLC10A1—Metabolism—NME1—peripheral nervous system neoplasm	9.7e-05	0.00225	CbGpPWpGaD
Ethinyl Estradiol—Back pain—Epirubicin—peripheral nervous system neoplasm	9.56e-05	0.000561	CcSEcCtD
Ethinyl Estradiol—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	9.53e-05	0.000559	CcSEcCtD
Ethinyl Estradiol—Dizziness—Etoposide—peripheral nervous system neoplasm	9.52e-05	0.000558	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	9.5e-05	0.000557	CcSEcCtD
Ethinyl Estradiol—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	9.49e-05	0.000557	CcSEcCtD
Ethinyl Estradiol—SLC10A1—Metabolism—COX2—peripheral nervous system neoplasm	9.33e-05	0.00216	CbGpPWpGaD
Ethinyl Estradiol—Nausea—Cisplatin—peripheral nervous system neoplasm	9.33e-05	0.000547	CcSEcCtD
Ethinyl Estradiol—Alopecia—Doxorubicin—peripheral nervous system neoplasm	9.29e-05	0.000544	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	9.27e-05	0.00215	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	9.27e-05	0.00215	CbGpPWpGaD
Ethinyl Estradiol—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	9.21e-05	0.00054	CcSEcCtD
Ethinyl Estradiol—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	9.17e-05	0.000538	CcSEcCtD
Ethinyl Estradiol—Vomiting—Etoposide—peripheral nervous system neoplasm	9.15e-05	0.000537	CcSEcCtD
Ethinyl Estradiol—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	9.15e-05	0.000536	CcSEcCtD
Ethinyl Estradiol—Rash—Etoposide—peripheral nervous system neoplasm	9.08e-05	0.000532	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Etoposide—peripheral nervous system neoplasm	9.07e-05	0.000532	CcSEcCtD
Ethinyl Estradiol—Headache—Etoposide—peripheral nervous system neoplasm	9.02e-05	0.000529	CcSEcCtD
Ethinyl Estradiol—ESR1—LKB1 signaling events—TP53—peripheral nervous system neoplasm	8.96e-05	0.00208	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	8.93e-05	0.00207	CbGpPWpGaD
Ethinyl Estradiol—Malaise—Epirubicin—peripheral nervous system neoplasm	8.91e-05	0.000523	CcSEcCtD
Ethinyl Estradiol—ESR1—Plasma membrane estrogen receptor signaling—HRAS—peripheral nervous system neoplasm	8.91e-05	0.00206	CbGpPWpGaD
Ethinyl Estradiol—Back pain—Doxorubicin—peripheral nervous system neoplasm	8.85e-05	0.000519	CcSEcCtD
Ethinyl Estradiol—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	8.79e-05	0.000516	CcSEcCtD
Ethinyl Estradiol—AOX1—Metabolism—GNS—peripheral nervous system neoplasm	8.7e-05	0.00202	CbGpPWpGaD
Ethinyl Estradiol—Cough—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.000506	CcSEcCtD
Ethinyl Estradiol—Nausea—Etoposide—peripheral nervous system neoplasm	8.55e-05	0.000501	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	8.49e-05	0.00197	CbGpPWpGaD
Ethinyl Estradiol—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	8.49e-05	0.000498	CcSEcCtD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	8.41e-05	0.00195	CbGpPWpGaD
Ethinyl Estradiol—Anxiety—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000492	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	8.36e-05	0.00049	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	8.35e-05	0.00194	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—NME1—peripheral nervous system neoplasm	8.34e-05	0.00193	CbGpPWpGaD
Ethinyl Estradiol—Discomfort—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.000488	CcSEcCtD
Ethinyl Estradiol—Malaise—Doxorubicin—peripheral nervous system neoplasm	8.25e-05	0.000484	CcSEcCtD
Ethinyl Estradiol—ABCB11—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.25e-05	0.00191	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	8.12e-05	0.00188	CbGpPWpGaD
Ethinyl Estradiol—Oedema—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000473	CcSEcCtD
Ethinyl Estradiol—AOX1—Metabolism—COX2—peripheral nervous system neoplasm	8.03e-05	0.00186	CbGpPWpGaD
Ethinyl Estradiol—Infection—Epirubicin—peripheral nervous system neoplasm	8.02e-05	0.00047	CcSEcCtD
Ethinyl Estradiol—Cough—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.000468	CcSEcCtD
Ethinyl Estradiol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—peripheral nervous system neoplasm	7.94e-05	0.00184	CbGpPWpGaD
Ethinyl Estradiol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.000464	CcSEcCtD
Ethinyl Estradiol—ESR1—Plasma membrane estrogen receptor signaling—AKT1—peripheral nervous system neoplasm	7.86e-05	0.00182	CbGpPWpGaD
Ethinyl Estradiol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	7.84e-05	0.00046	CcSEcCtD
Ethinyl Estradiol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.000455	CcSEcCtD
Ethinyl Estradiol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	7.73e-05	0.000453	CcSEcCtD
Ethinyl Estradiol—Discomfort—Doxorubicin—peripheral nervous system neoplasm	7.69e-05	0.000451	CcSEcCtD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	7.6e-05	0.00176	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—MYC—peripheral nervous system neoplasm	7.57e-05	0.00175	CbGpPWpGaD
Ethinyl Estradiol—Oedema—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000438	CcSEcCtD
Ethinyl Estradiol—Infection—Doxorubicin—peripheral nervous system neoplasm	7.42e-05	0.000435	CcSEcCtD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	7.39e-05	0.00171	CbGpPWpGaD
Ethinyl Estradiol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.000429	CcSEcCtD
Ethinyl Estradiol—AOX1—Disease—PPP3R1—peripheral nervous system neoplasm	7.26e-05	0.00168	CbGpPWpGaD
Ethinyl Estradiol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	7.25e-05	0.000425	CcSEcCtD
Ethinyl Estradiol—ESR1—Gene Expression—EED—peripheral nervous system neoplasm	7.16e-05	0.00166	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—PTPN11—peripheral nervous system neoplasm	7.1e-05	0.00165	CbGpPWpGaD
Ethinyl Estradiol—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	6.97e-05	0.000408	CcSEcCtD
Ethinyl Estradiol—Fatigue—Epirubicin—peripheral nervous system neoplasm	6.96e-05	0.000408	CcSEcCtD
Ethinyl Estradiol—Constipation—Epirubicin—peripheral nervous system neoplasm	6.9e-05	0.000405	CcSEcCtD
Ethinyl Estradiol—ABCB11—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.85e-05	0.00159	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	6.65e-05	0.00039	CcSEcCtD
Ethinyl Estradiol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	6.6e-05	0.000387	CcSEcCtD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—peripheral nervous system neoplasm	6.58e-05	0.00152	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	6.57e-05	0.00152	CbGpPWpGaD
Ethinyl Estradiol—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.000378	CcSEcCtD
Ethinyl Estradiol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.000377	CcSEcCtD
Ethinyl Estradiol—Urticaria—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000376	CcSEcCtD
Ethinyl Estradiol—Constipation—Doxorubicin—peripheral nervous system neoplasm	6.38e-05	0.000374	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	6.38e-05	0.000374	CcSEcCtD
Ethinyl Estradiol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	6.38e-05	0.000374	CcSEcCtD
Ethinyl Estradiol—AOX1—Disease—ENO2—peripheral nervous system neoplasm	6.29e-05	0.00146	CbGpPWpGaD
Ethinyl Estradiol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	6.15e-05	0.000361	CcSEcCtD
Ethinyl Estradiol—SLC10A1—Metabolism—ENO2—peripheral nervous system neoplasm	6.13e-05	0.00142	CbGpPWpGaD
Ethinyl Estradiol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.000358	CcSEcCtD
Ethinyl Estradiol—ESR1—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	6.07e-05	0.00141	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—GNS—peripheral nervous system neoplasm	5.96e-05	0.00138	CbGpPWpGaD
Ethinyl Estradiol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000349	CcSEcCtD
Ethinyl Estradiol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000348	CcSEcCtD
Ethinyl Estradiol—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.91e-05	0.00137	CbGpPWpGaD
Ethinyl Estradiol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.000346	CcSEcCtD
Ethinyl Estradiol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.000346	CcSEcCtD
Ethinyl Estradiol—Asthenia—Epirubicin—peripheral nervous system neoplasm	5.79e-05	0.000339	CcSEcCtD
Ethinyl Estradiol—ESR1—Gene Expression—SUZ12—peripheral nervous system neoplasm	5.73e-05	0.00133	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—NME1—peripheral nervous system neoplasm	5.72e-05	0.00132	CbGpPWpGaD
Ethinyl Estradiol—Pruritus—Epirubicin—peripheral nervous system neoplasm	5.71e-05	0.000335	CcSEcCtD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—ERBB2—peripheral nervous system neoplasm	5.61e-05	0.0013	CbGpPWpGaD
Ethinyl Estradiol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.52e-05	0.000324	CcSEcCtD
Ethinyl Estradiol—ABCB11—Metabolism—COX2—peripheral nervous system neoplasm	5.5e-05	0.00128	CbGpPWpGaD
Ethinyl Estradiol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.000323	CcSEcCtD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—HRAS—peripheral nervous system neoplasm	5.49e-05	0.00127	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	5.39e-05	0.00125	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	5.38e-05	0.00125	CbGpPWpGaD
Ethinyl Estradiol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	5.36e-05	0.000314	CcSEcCtD
Ethinyl Estradiol—Dizziness—Epirubicin—peripheral nervous system neoplasm	5.34e-05	0.000313	CcSEcCtD
Ethinyl Estradiol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.00031	CcSEcCtD
Ethinyl Estradiol—AOX1—Metabolism—ENO2—peripheral nervous system neoplasm	5.27e-05	0.00122	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of Telomerase—AKT1—peripheral nervous system neoplasm	5.25e-05	0.00122	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	5.2e-05	0.00121	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—BCHE—peripheral nervous system neoplasm	5.18e-05	0.0012	CbGpPWpGaD
Ethinyl Estradiol—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.13e-05	0.000301	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	5.12e-05	0.00119	CbGpPWpGaD
Ethinyl Estradiol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.11e-05	0.0003	CcSEcCtD
Ethinyl Estradiol—Rash—Epirubicin—peripheral nervous system neoplasm	5.09e-05	0.000298	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000298	CcSEcCtD
Ethinyl Estradiol—AOX1—Disease—SLC2A1—peripheral nervous system neoplasm	5.07e-05	0.00118	CbGpPWpGaD
Ethinyl Estradiol—Headache—Epirubicin—peripheral nervous system neoplasm	5.05e-05	0.000296	CcSEcCtD
Ethinyl Estradiol—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.01e-05	0.00116	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.94e-05	0.00114	CbGpPWpGaD
Ethinyl Estradiol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.94e-05	0.000289	CcSEcCtD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	4.91e-05	0.00114	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—TH—peripheral nervous system neoplasm	4.87e-05	0.00113	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Leptin signaling pathway—AKT1—peripheral nervous system neoplasm	4.85e-05	0.00112	CbGpPWpGaD
Ethinyl Estradiol—Nausea—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000281	CcSEcCtD
Ethinyl Estradiol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.75e-05	0.000278	CcSEcCtD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.72e-05	0.0011	CbGpPWpGaD
Ethinyl Estradiol—Rash—Doxorubicin—peripheral nervous system neoplasm	4.71e-05	0.000276	CcSEcCtD
Ethinyl Estradiol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000276	CcSEcCtD
Ethinyl Estradiol—Headache—Doxorubicin—peripheral nervous system neoplasm	4.68e-05	0.000274	CcSEcCtD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	4.67e-05	0.00108	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	4.64e-05	0.00107	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—peripheral nervous system neoplasm	4.56e-05	0.00106	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	4.55e-05	0.00106	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	4.55e-05	0.00105	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	4.49e-05	0.00104	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—BCHE—peripheral nervous system neoplasm	4.45e-05	0.00103	CbGpPWpGaD
Ethinyl Estradiol—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.00026	CcSEcCtD
Ethinyl Estradiol—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.36e-05	0.00101	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—NRAS—peripheral nervous system neoplasm	4.27e-05	0.000989	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.25e-05	0.000985	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	4.24e-05	0.000983	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.2e-05	0.000973	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—TH—peripheral nervous system neoplasm	4.19e-05	0.00097	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	4e-05	0.000926	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	4e-05	0.000926	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—GNAS—peripheral nervous system neoplasm	3.97e-05	0.000921	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.9e-05	0.000904	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.8e-05	0.000881	CbGpPWpGaD
Ethinyl Estradiol—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.73e-05	0.000865	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—ENO2—peripheral nervous system neoplasm	3.61e-05	0.000837	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—GNAS—peripheral nervous system neoplasm	3.42e-05	0.000792	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.38e-05	0.000784	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	3.37e-05	0.00078	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—ABCB1—peripheral nervous system neoplasm	3.35e-05	0.000777	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	3.31e-05	0.000768	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	3.28e-05	0.000761	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	3.26e-05	0.000756	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	3.23e-05	0.000748	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	3.12e-05	0.000724	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—BCHE—peripheral nervous system neoplasm	3.05e-05	0.000707	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.95e-05	0.000683	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.91e-05	0.000675	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	2.89e-05	0.00067	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—TH—peripheral nervous system neoplasm	2.87e-05	0.000665	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.84e-05	0.000659	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—PTPN11—peripheral nervous system neoplasm	2.84e-05	0.000657	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.81e-05	0.000652	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.77e-05	0.000642	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	2.77e-05	0.000642	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	2.76e-05	0.000639	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.72e-05	0.00063	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.69e-05	0.000623	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	2.67e-05	0.000618	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.55e-05	0.000591	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	2.47e-05	0.000573	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	2.45e-05	0.000567	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.35e-05	0.000546	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	2.34e-05	0.000543	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—GNAS—peripheral nervous system neoplasm	2.34e-05	0.000543	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—ABCB1—peripheral nervous system neoplasm	2.3e-05	0.000533	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.3e-05	0.000532	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	2.26e-05	0.000523	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	2.24e-05	0.00052	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—ERBB2—peripheral nervous system neoplasm	2.24e-05	0.000519	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—MYC—peripheral nervous system neoplasm	2.23e-05	0.000517	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.22e-05	0.000515	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	2.13e-05	0.000494	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	2.04e-05	0.000473	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.97e-05	0.000456	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.82e-05	0.000421	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.79e-05	0.000414	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.77e-05	0.00041	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.75e-05	0.000406	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	1.75e-05	0.000406	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—NRAS—peripheral nervous system neoplasm	1.71e-05	0.000395	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.64e-05	0.000381	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—MYC—peripheral nervous system neoplasm	1.59e-05	0.000368	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—MYC—peripheral nervous system neoplasm	1.57e-05	0.000364	CbGpPWpGaD
Ethinyl Estradiol—NR1I2—Gene Expression—AKT1—peripheral nervous system neoplasm	1.55e-05	0.000359	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.51e-05	0.000351	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	1.48e-05	0.000343	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	1.48e-05	0.000343	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.44e-05	0.000334	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.44e-05	0.000333	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.41e-05	0.000327	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	1.39e-05	0.000322	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.32e-05	0.000307	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.31e-05	0.000304	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.29e-05	0.000299	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.26e-05	0.000292	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	1.25e-05	0.00029	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—HRAS—peripheral nervous system neoplasm	1.25e-05	0.000289	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.21e-05	0.000282	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.21e-05	0.000281	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.19e-05	0.000277	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	1.18e-05	0.000273	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	1.13e-05	0.000263	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.11e-05	0.000258	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Disease—AKT1—peripheral nervous system neoplasm	1.1e-05	0.000255	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	1.09e-05	0.000253	CbGpPWpGaD
Ethinyl Estradiol—ESR2—Gene Expression—AKT1—peripheral nervous system neoplasm	1.09e-05	0.000252	CbGpPWpGaD
Ethinyl Estradiol—SLC10A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.07e-05	0.000249	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.04e-05	0.000241	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	1.03e-05	0.000238	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	9.61e-06	0.000223	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	9.43e-06	0.000219	CbGpPWpGaD
Ethinyl Estradiol—AOX1—Metabolism—AKT1—peripheral nervous system neoplasm	9.22e-06	0.000214	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.19e-06	0.000213	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	8.37e-06	0.000194	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	7.95e-06	0.000184	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—MYC—peripheral nervous system neoplasm	7.92e-06	0.000184	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.27e-06	0.000168	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	6.72e-06	0.000156	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.6e-06	0.000153	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.41e-06	0.000149	CbGpPWpGaD
Ethinyl Estradiol—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	6.32e-06	0.000147	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	6.32e-06	0.000146	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.53e-06	0.000128	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Gene Expression—AKT1—peripheral nervous system neoplasm	5.49e-06	0.000127	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	5.16e-06	0.00012	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.15e-06	0.000119	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	5.06e-06	0.000117	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.23e-06	9.8e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.04e-06	9.37e-05	CbGpPWpGaD
Ethinyl Estradiol—ESR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.57e-06	8.28e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	3.06e-06	7.1e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	2.59e-06	6.01e-05	CbGpPWpGaD
Ethinyl Estradiol—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	2.26e-06	5.24e-05	CbGpPWpGaD
Ethinyl Estradiol—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.39e-06	3.23e-05	CbGpPWpGaD
